Reuters Health Report

Click to View in Browser 05/28/2014 Sanofi, Lilly pursue Cialis over-the-counter approval PARIS (Reuters) - Sanofi and Eli Lilly and Co have agreed to pursue regulatory approval for over-the-counter sales of erectile dysfunction treatment Cialis, the French and U.S. drugmakers said in a statement on Wednesday. West Africa Ebola outbreak still spreading, 'situation serious': WHO GENEVA/CONAKRY (Reuters) - Guinea's capital Conakry has recorded its first new Ebola cases in more than a month, while other previously unaffected areas have also reported infections in the past week, according to the World Health Organization. Boehringer to settle lawsuits against blockbuster drug for $650 million (Reuters) - German drugmaker Boehringer Ingelheim said it would pay about $650 million to settle U.S. lawsuits that claimed the company's blockbuster blood thinner Pradaxa had caused severe and fatal bleeding in patients. Acura shares fall on FDA uncertainty over abuse-resistant painkiller (Reuters) - Acura Pharmaceuticals Inc's shares fell as much as 21 percent to a life low on Wednesday, a day after the U.S. health regulator said data on its experimental painkiller was insufficient to support its claim that the drug could not be abused by snorting. Trimel's sexual disorder drug effective in mid-stage study (Reuters) - Trimel Pharmaceuticals Corp said its experimental sexual disorder drug increased the average number of orgasms in women with an orgasmic disorder in a second mid-stage study. Novo Nordisk changes strategy in Germany, launches diabetes drug COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug Tresiba in Germany on May 1 after seeing signs of a more favourable pricing situation there. Insurers scrutinize drug costs after $84,000 Sovaldi surprise NEW YORK/LOS ANGELES (Reuters) - Shocked by the rapid adoption of a new $84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren't blindsided by other drugs being developed and are looking for ways to limit their use from the day they are launched. Economic slowdown tied to rise in obesity in richer nations: OECD WASHINGTON (Reuters) - The rate of obesity continues to climb across the world's most developed countries, with certain nations and groups of people such as women and the poor hit harder by the recent economic crisis, the OECD said on Tuesday. Brain activity changes seen after chemo NEW YORK (Reuters Health) - For some women with breast cancer, changes in brain activity while multitasking could explain "chemo brain" – reduced mental functioning that many experience after chemotherapy, Belgian researchers say. Allergan makes case against Valeant takeover ahead of higher bid (Reuters) - Allergan Inc on Tuesday built its case with investors for rejecting a $47 billion takeover offer from Valeant Pharmaceuticals International, , saying the Canadian drugmaker has overstated the possible savings from the deal. Related Video Researchers see solar-powered cars on the road ahead Scans reveal snout nervous system of the mighty pliosaur The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend